Aims:The aim was to compare Acute Kidney Injury (AKI) incidence and outcomes among Surgical Aortic Valve Replacement (SAVR) vs Transcatheter Aortic Valve Implantation (TAVI) patients.Methods: Patients undergoing SAVR or TAVI for severe aortic valve stenosis from 09/2017 to 12/2019 were enrolled. The primary endpoint was post-procedural AKI. Main secondary endpoints were AKI at discharge, 30-day and 1-year mortality.Results: 457 patients (SAVR: 201 [44.0%]; TAVI: 256 [56.0%]) were enrolled. The incidence of AKI was higher in the SAVR group (n=58/201 [28.9%] vs 15/256 [5.9%], p<0.001). At discharge, the percentage of AKI patients was higher in the TAVI group (n=8/15 [53.3%] vs 9/58 [15.5%], p<0.001). A significantly higher 30-day and 1-year mortality were recorded among AKI vs no-AKI patients in both groups (30-day mortality: n=5/58 [8.6%] vs 1/143 [0.7%], p=0.01 for SAVR; n=3/15 [20.0%] vs 1/241 [0.4%], p<0.001 for TAVI. 1-year mortality: n=8/58 [13.8%] vs 5/143 [3.5%], p=0.01 for SAVR; n=5/15 [33.3%] vs 21/241 [8.7%], p=0.02 for TAVI). In the SAVR group, the Kaplan-Meier 1-year survival estimate was 96.5% for no-AKI patients and 67.0% for AKI III patients (log-rank p<0.001). In the TAVI group, it was 91.5% for no-AKI patients and 16.5% for AKI III patients (log-rank p<0.001).Conclusions: AKI is a risk factor for 30-day and 1-year mortality in both SAVR and TAVI patients. Despite the higher AKI incidence in SAVR patients, it lasted longer in TAVI patients. TAVI patients with severe AKI had a lower estimate 1-year survival compared to SAVR patients in the same category.